TGFBR2 and lung carcinoma: Another study supported exomiR as a promising therapy in lung cancer as it demonstrated that exosome-derived miR-302b could significantly suppress lung cancer cell proliferation and migration via the transforming growth factor-beta receptor II/extracellular-signal-regulated kinase pathway [105].